|تعداد مشاهده مقاله||12,902,698|
|تعداد دریافت فایل اصل مقاله||6,147,565|
Prevalence of HIVAb, HbsAg, and HCVAb in Iranian Blood Donors in 2018: A Short Communication
|Journal of Health Sciences & Surveillance System|
|دوره 11، شماره 2، تیر 2023، صفحه 393-395 اصل مقاله (283.08 K)|
|نوع مقاله: Short Communication|
|شناسه دیجیتال (DOI): 10.30476/jhsss.2021.92953.1404|
|Moslem Soodejani1؛ Ali Akbar Haghdoost2؛ Mohammad Reza Baneshi3؛ Abbas Sedaghat4؛ Seyyed Mohammad Tabatabaei5؛ Farzaneh Zolala* 6|
|1Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran|
|2HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran|
|3Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran|
|4Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran|
|5Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran|
|6Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran|
|Background: The prevalence of infections among general population can affect the prevalence among blood donors. Due to to the importance of blood safety, this study was conducted to estimate the prevalence of HIV, HBV, and HCV in donated bloods in Iran in 2018.|
Methods: Using information of 1,308,284 blood donors, we designed this cross-sectional study to estimate the prevalence of transfusion-transmitted infections (TTIs) in Iranian blood donors. All the prevalence was reported per 100,000 population.
Results: HIV prevalence in blood donors was about 2 per 100,000 (95% CI: 1.999, 2.001) population. Prevalence of HBV and HCV was 53(95% CI: 52.999-53.00) and 26 (95% CI: 25.999-26.001), respectively.
Conclusion: It seems that the screening of volunteers would defer many people who may have been infected with TTIs; as a result, people with the least risk of being infected are selected to donate blood. Notice: All of these infected bloods were detected and discarded from the blood donation chain.
|Transfusion transmitted infections؛ Blood donation؛ Safety|
تعداد مشاهده مقاله: 179
تعداد دریافت فایل اصل مقاله: 110